Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-4838
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model ; volume:24 ; number:1 ; day:27 ; month:9 ; year:2012 ; pages:115-127 ; date:1.2013
Journal of materials science / Materials in medicine ; 24, Heft 1 (27.9.2012), 115-127, 1.2013
- Urheber
-
Lewis, Andrew L.
Holden, Rachel R.
Chung, S. Ting
Czuczman, Peter
Kuchel, Timothy
Finnie, John
Porter, Susan
Foster, David
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10856-012-4768-2
- URN
-
urn:nbn:de:101:1-2019062722403168677654
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lewis, Andrew L.
- Holden, Rachel R.
- Chung, S. Ting
- Czuczman, Peter
- Kuchel, Timothy
- Finnie, John
- Porter, Susan
- Foster, David
- SpringerLink (Online service)
Ähnliche Objekte (12)
Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
VEGF-Serum-Spiegel nach Chemoembolisation mit Irinotecan-beladenen Drug-Eluting Beads als prognostischer oder prädiktiver Marker bei Patienten mit Lebermetastasen kolorektaler Karzinome
Drug-eluting coating of extruded polymeric tubular microstructures
Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
VEGF-Serum-Spiegel nach Chemoembolisation mit Irinotecan-beladenen Drug-Eluting Beads als prognostischer oder prädiktiver Marker bei Patienten mit Lebermetastasen kolorektaler Karzinome
Drug-eluting coating of extruded polymeric tubular microstructures
Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
VEGF-Serum-Spiegel nach Chemoembolisation mit Irinotecan-beladenen Drug-Eluting Beads als prognostischer oder prädiktiver Marker bei Patienten mit Lebermetastasen kolorektaler Karzinome
Drug-eluting coating of extruded polymeric tubular microstructures
Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials